JP2008508265A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008508265A5 JP2008508265A5 JP2007523501A JP2007523501A JP2008508265A5 JP 2008508265 A5 JP2008508265 A5 JP 2008508265A5 JP 2007523501 A JP2007523501 A JP 2007523501A JP 2007523501 A JP2007523501 A JP 2007523501A JP 2008508265 A5 JP2008508265 A5 JP 2008508265A5
- Authority
- JP
- Japan
- Prior art keywords
- medicament according
- medicament
- infection
- amino acid
- local
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04077175A EP1621205A1 (en) | 2004-07-28 | 2004-07-28 | Antimicrobial peptides derived from CAP18 |
| PCT/NL2005/000545 WO2006011792A2 (en) | 2004-07-28 | 2005-07-26 | Antimicrobial peptides derived from cap18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008508265A JP2008508265A (ja) | 2008-03-21 |
| JP2008508265A5 true JP2008508265A5 (enExample) | 2008-09-11 |
Family
ID=34928414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007523501A Pending JP2008508265A (ja) | 2004-07-28 | 2005-07-26 | 抗菌性ペプチド |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7803756B2 (enExample) |
| EP (3) | EP1621205A1 (enExample) |
| JP (1) | JP2008508265A (enExample) |
| KR (1) | KR20070050941A (enExample) |
| CN (1) | CN101018563A (enExample) |
| AU (1) | AU2005267651B2 (enExample) |
| BR (1) | BRPI0513856A (enExample) |
| CA (1) | CA2574959A1 (enExample) |
| NZ (1) | NZ553175A (enExample) |
| RU (1) | RU2392962C2 (enExample) |
| WO (1) | WO2006011792A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1621205A1 (en) * | 2004-07-28 | 2006-02-01 | OctoPlus Technologies B.V. | Antimicrobial peptides derived from CAP18 |
| US20100209411A1 (en) | 2006-12-01 | 2010-08-19 | Laclede, Inc. | Use of hydrolytic and oxidative enzymes to dissolve biofilm in ears |
| WO2009015336A2 (en) | 2007-07-25 | 2009-01-29 | Biolex Therapeutics, Inc. | Controlled release interferon drug products and treatment of hcv infection using same |
| US20100184684A1 (en) * | 2009-01-06 | 2010-07-22 | C3 Jian, Inc. | Antibacterial and antifungal peptides |
| AU2010306940A1 (en) | 2009-10-12 | 2012-06-07 | Smith, Larry | Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro |
| RU2434880C1 (ru) * | 2010-07-21 | 2011-11-27 | Общество С Ограниченной Ответственностью "Биохарт" | Полипептид, имеющий антибактериальную активность и пригодный для получения лекарственных средств для лечения бактериальных инфекций человека |
| KR20200023521A (ko) * | 2012-05-09 | 2020-03-04 | 콘트라펙트 코포레이션 | 박테리오파지 리신을 이용한 생물막의 예방, 붕괴 및 치료 |
| AU2014263279B2 (en) * | 2013-05-10 | 2018-02-15 | Academisch Ziekenhuis Leiden H.O.D.N. Lumc | Antimicrobial peptide |
| US9387189B2 (en) | 2013-05-22 | 2016-07-12 | Professional Compounding Centers Of America (Pcca) | Antibiotic composition comprising a chemotactic agent and a nutrient dispersion |
| WO2015075406A1 (en) * | 2013-11-19 | 2015-05-28 | Lipopeptide Ab | New treatment of chronic ulcers |
| AU2014360942B2 (en) * | 2013-12-12 | 2018-12-13 | Academisch Medisch Centrum | Antimicrobial peptide and uses thereof |
| WO2015164289A1 (en) * | 2014-04-21 | 2015-10-29 | Cidara Therapeutics, Inc. | Compositions and methods for the treatment of fungal infections |
| US20250034218A1 (en) * | 2021-09-21 | 2025-01-30 | Biomedit, Llc | Antimicrobial peptides |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4037525B2 (ja) * | 1998-03-25 | 2008-01-23 | 生化学工業株式会社 | 新規抗菌性ペプチド |
| MXPA05008080A (es) * | 2003-01-28 | 2006-02-08 | Octoplus Technologies B V | Inhibidores peptidicos de toxinas derivadas de la ll-37. |
| CN1878789A (zh) | 2003-10-21 | 2006-12-13 | 加利福尼亚大学董事会 | 人凯萨林菌素抗微生物肽 |
| EP1621205A1 (en) * | 2004-07-28 | 2006-02-01 | OctoPlus Technologies B.V. | Antimicrobial peptides derived from CAP18 |
-
2004
- 2004-07-28 EP EP04077175A patent/EP1621205A1/en not_active Withdrawn
-
2005
- 2005-07-26 US US11/658,415 patent/US7803756B2/en not_active Expired - Fee Related
- 2005-07-26 JP JP2007523501A patent/JP2008508265A/ja active Pending
- 2005-07-26 RU RU2007107390/15A patent/RU2392962C2/ru not_active IP Right Cessation
- 2005-07-26 CA CA002574959A patent/CA2574959A1/en not_active Abandoned
- 2005-07-26 KR KR1020077004988A patent/KR20070050941A/ko not_active Withdrawn
- 2005-07-26 AU AU2005267651A patent/AU2005267651B2/en not_active Ceased
- 2005-07-26 CN CNA2005800255122A patent/CN101018563A/zh active Pending
- 2005-07-26 EP EP09158381A patent/EP2221061A1/en not_active Withdrawn
- 2005-07-26 WO PCT/NL2005/000545 patent/WO2006011792A2/en not_active Ceased
- 2005-07-26 NZ NZ553175A patent/NZ553175A/en unknown
- 2005-07-26 EP EP05769152A patent/EP1784206A2/en not_active Withdrawn
- 2005-07-26 BR BRPI0513856-6A patent/BRPI0513856A/pt not_active IP Right Cessation
-
2010
- 2010-09-14 US US12/882,089 patent/US20110053835A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9227999B2 (en) | Antimicrobial cationic peptides and formulations thereof | |
| ES2264198T3 (es) | Composiciones y metodos para tratar infecciones utilizando peptidos cationicos a solas o en combinacion con antibioticos. | |
| US6894028B2 (en) | Use of KPV tripeptide for dermatological disorders | |
| KR101922409B1 (ko) | 화합물들 및 그 용도 | |
| JP2008508265A5 (enExample) | ||
| US6780838B2 (en) | Compounds for treating fungal pathologies of the oral cavity | |
| JP2012522037A5 (enExample) | ||
| Casciaro et al. | The Potential of frog skin peptides for anti-Infective therapies: the Case of Esculentin-1a (1-21) NH2 | |
| US20110053835A1 (en) | Antimicrobial peptides derived from cap18 | |
| WO2004103315A3 (en) | Treatment of ophthalmic infections using antimicrobial peptides | |
| KR20210024005A (ko) | 스태필로코커스 아우레우스 및 그람 양성 세균을 항생제에 재민감화시키기 위한 리신 및 이의 유도체 | |
| JP2010517987A (ja) | 塩基性ペプチド及びその複合型抗細菌−抗真菌剤としての使用 | |
| US10507227B2 (en) | Cationic antimicrobial peptides | |
| CA2514584A1 (en) | Peptide inhibitors of toxins derived from ll-37 | |
| US20050074485A1 (en) | Anti-inflammatory/anti-microbial peptides for use in dialysis | |
| Walsh et al. | Extended nasal residence time of lysostaphin and an anti-staphylococcal monoclonal antibody by delivery in semisolid or polymeric carriers | |
| KR101173696B1 (ko) | 플루오로퀴놀론의 국소 적용에 의한 호흡 기관의 세균성질환의 치료 | |
| JP2018530622A (ja) | 尿路感染症を治療するための組成物および方法 | |
| CN109715152A (zh) | 医治感染的方法 | |
| Gomes | Piling-Peptide-Based Ionic Liquids Towards Healing of Complicated Skin Infections | |
| US20160317467A1 (en) | Method of treating or preventing infection | |
| JP2002161041A (ja) | 感染症治療剤 | |
| EP1758922B8 (en) | Peptide substance restoring function of respiratory organs | |
| WO2014205157A1 (en) | Inhalation composition for treating respiratory tract infections | |
| WO2022261360A1 (en) | Plyss2 lysins and variants thereof for use against multidrug resistant gram-positive bacteria |